These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 28182168)

  • 1. Drugs in development for toxoplasmosis: advances, challenges, and current status.
    Alday PH; Doggett JS
    Drug Des Devel Ther; 2017; 11():273-293. PubMed ID: 28182168
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening.
    Deng Y; Wu T; Zhai SQ; Li CH
    Eur J Med Chem; 2019 Dec; 183():111711. PubMed ID: 31585276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of a library of traditional Chinese medicines to identify compounds and extracts which inhibit Toxoplasma gondii growth.
    Saito H; Murata Y; Nonaka M; Kato K
    J Vet Med Sci; 2020 Feb; 82(2):184-187. PubMed ID: 31904004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antibacterials for the treatment of toxoplasmosis; a patent review.
    Rodriguez JB; Szajnman SH
    Expert Opin Ther Pat; 2012 Mar; 22(3):311-33. PubMed ID: 22404108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human toxoplasmosis-Searching for novel chemotherapeutics.
    Antczak M; Dzitko K; Długońska H
    Biomed Pharmacother; 2016 Aug; 82():677-84. PubMed ID: 27470411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in researches on mechanism of anti-Toxoplasma Chinese herbal medicine].
    Yu ZY; Zhang BD; Ning JY; Wang YY; Yuan WY
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2015 Oct; 27(5):555-7, 559. PubMed ID: 26930953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of
    Alday PH; Nilsen A; Doggett JS
    Expert Opin Drug Discov; 2022 Sep; 17(9):997-1011. PubMed ID: 35772172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for small molecule inhibitors of Toxoplasma gondii.
    Kortagere S
    Expert Opin Drug Discov; 2012 Dec; 7(12):1193-206. PubMed ID: 22998671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
    el Kouni MH
    Curr Pharm Des; 2007; 13(6):581-97. PubMed ID: 17346176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.
    Mui EJ; Schiehser GA; Milhous WK; Hsu H; Roberts CW; Kirisits M; Muench S; Rice D; Dubey JP; Fowble JW; Rathod PK; Queener SF; Liu SR; Jacobus DP; McLeod R
    PLoS Negl Trop Dis; 2008 Mar; 2(3):e190. PubMed ID: 18320016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
    Murata Y; Sugi T; Weiss LM; Kato K
    PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection.
    Doggett JS; Ojo KK; Fan E; Maly DJ; Van Voorhis WC
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3547-9. PubMed ID: 24687502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
    McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
    ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketolide ABT-773 is active against Toxoplasma gondii.
    Khan AA; Araujo FG; Craft JC; Remington JS
    J Antimicrob Chemother; 2000 Sep; 46(3):489-92. PubMed ID: 10980181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytochemicals and Potential Therapeutic Targets on Toxoplasma gondii Parasite.
    Abdullahi SA; Unyah NZ; Nordin N; Basir R; Nasir WM; Alapid AA; Hassan Y; Mustapha T; Majid RA
    Mini Rev Med Chem; 2020; 20(9):739-753. PubMed ID: 31660810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity.
    Neville AJ; Zach SJ; Wang X; Larson JJ; Judge AK; Davis LA; Vennerstrom JL; Davis PH
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7161-9. PubMed ID: 26392504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.
    Vidadala RS; Rivas KL; Ojo KK; Hulverson MA; Zambriski JA; Bruzual I; Schultz TL; Huang W; Zhang Z; Scheele S; DeRocher AE; Choi R; Barrett LK; Siddaramaiah LK; Hol WG; Fan E; Merritt EA; Parsons M; Freiberg G; Marsh K; Kempf DJ; Carruthers VB; Isoherranen N; Doggett JS; Van Voorhis WC; Maly DJ
    J Med Chem; 2016 Jul; 59(13):6531-46. PubMed ID: 27309760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review.
    Montazeri M; Mehrzadi S; Sharif M; Sarvi S; Shahdin S; Daryani A
    Parasitol Res; 2018 Oct; 117(10):3045-3057. PubMed ID: 30088074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis.
    Rocha-Roa C; Molina D; Cardona N
    Front Cell Infect Microbiol; 2018; 8():360. PubMed ID: 30386743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.